141 related articles for article (PubMed ID: 19247180)
1. Beta-catenin expression is altered in dysplastic and nondysplastic aberrant crypt foci of human colon.
Mi B; Wang X; Bai Y; Gong W; Wang X; Geng Y; Wang J; Zhang H; Jiang B
Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):294-300. PubMed ID: 19247180
[TBL] [Abstract][Full Text] [Related]
2. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.
Takayama T; Ohi M; Hayashi T; Miyanishi K; Nobuoka A; Nakajima T; Satoh T; Takimoto R; Kato J; Sakamaki S; Niitsu Y
Gastroenterology; 2001 Sep; 121(3):599-611. PubMed ID: 11522744
[TBL] [Abstract][Full Text] [Related]
3. Beta-catenin expression is altered in human colonic aberrant crypt foci.
Hao XP; Pretlow TG; Rao JS; Pretlow TP
Cancer Res; 2001 Nov; 61(22):8085-8. PubMed ID: 11719432
[TBL] [Abstract][Full Text] [Related]
4. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
[TBL] [Abstract][Full Text] [Related]
6. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
[TBL] [Abstract][Full Text] [Related]
7. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of PPARbeta/delta and cyclin D1 in flat dysplastic ACF and adenomas in Apc(Min/+) mice.
Knutsen HK; Olstørn HB; Paulsen JE; Husøy T; Goverud IL; Løberg EM; Kristiansen K; Alexander J
Anticancer Res; 2005; 25(6B):3781-9. PubMed ID: 16309164
[TBL] [Abstract][Full Text] [Related]
9. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
[TBL] [Abstract][Full Text] [Related]
10. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions.
Sena P; Saviano M; Monni S; Losi L; Roncucci L; Marzona L; De Pol A
Cancer Lett; 2006 Sep; 241(2):203-12. PubMed ID: 16298038
[TBL] [Abstract][Full Text] [Related]
11. Identification of High-Risk Aberrant Crypt Foci and Mucin-Depleted Foci in the Human Colon With Study of Colon Cancer Stem Cell Markers.
Gupta B; Das P; Ghosh S; Manhas J; Sen S; Pal S; Sahni P; Upadhyay AD; Panda SK; Gupta SD
Clin Colorectal Cancer; 2017 Sep; 16(3):204-213. PubMed ID: 27789195
[TBL] [Abstract][Full Text] [Related]
12. Gene expression patterns distinguish colonoscopically isolated human aberrant crypt foci from normal colonic mucosa.
Glebov OK; Rodriguez LM; Soballe P; DeNobile J; Cliatt J; Nakahara K; Kirsch IR
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2253-62. PubMed ID: 17119054
[TBL] [Abstract][Full Text] [Related]
13. Histomorphology of aberrant crypt foci in colorectal carcinoma.
Norlida AO; Phang KS
Malays J Pathol; 2010 Dec; 32(2):111-6. PubMed ID: 21329182
[TBL] [Abstract][Full Text] [Related]
14. Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane-treated A/J mice.
Paulsen JE; Knutsen H; Ølstørn HB; Løberg EM; Alexander J
Int J Cancer; 2006 Feb; 118(3):540-6. PubMed ID: 16094649
[TBL] [Abstract][Full Text] [Related]
15. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease.
Bouzourene H; Chaubert P; Seelentag W; Bosman FT; Saraga E
Hum Pathol; 1999 Jan; 30(1):66-71. PubMed ID: 9923929
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the malignant potential of aberrant crypt foci by immunohistochemical staining for beta-catenin in inflammation-induced rat colon carcinogenesis.
Furihata T; Kawamata H; Kubota K; Fujimori T
Int J Mol Med; 2002 Apr; 9(4):353-8. PubMed ID: 11891526
[TBL] [Abstract][Full Text] [Related]
17. Pre-cancerous lesions for colorectal cancers in rodents: a new concept.
Yamada Y; Mori H
Carcinogenesis; 2003 Jun; 24(6):1015-9. PubMed ID: 12807742
[TBL] [Abstract][Full Text] [Related]
18. Abberant crypt foci -- importance in colorectal carcinogenesis and expression of p53 and mdm2: a changing concept.
Das P; Jain D; Vaiphei K; Wig JD
Dig Dis Sci; 2008 Aug; 53(8):2183-8. PubMed ID: 18080767
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer.
Luo L; Shen GQ; Stiffler KA; Wang QK; Pretlow TG; Pretlow TP
Carcinogenesis; 2006 Jun; 27(6):1153-9. PubMed ID: 16474178
[TBL] [Abstract][Full Text] [Related]
20. [Aberrant crypt foci and cancer of the colorectal junction: the correlation between beta-catenin/Ki-67 expression and the occurrence of early microscopic secondary lesions surrounding periphery colorectal cancer].
Ogata DC; Greca FH; Luz Mde A; Ioshii SO; Tomasich FD
Rev Col Bras Cir; 2010 Apr; 37(2):114-20. PubMed ID: 20549101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
